c-Met Second-Line Hepatocellular Carcinoma

Clinical trial NCT02115373 · COMPLETED

Trial details

NCT number: NCT02115373
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2014-05-18
Primary completion: 2018-02-14
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.